NRXS · Neuraxis Inc
United States · RS rating 76 · As of 2026-10-14
| Price | 6.53 USD |
|---|---|
| 1-day change | +0.5% |
| RS rating (overall / 1M / 3M / 12M) | 76 / 95 / 48 / 96 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 35 / 27 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -5.6% |
| Sales growth Q/Q | +19.3% |
| Distance from 52-week high | +25.9% |
| Market cap (USD) | $85.7M |